Format
Sort by

Send to:

Choose Destination

Results: 4

1.

Lasofoxifene in postmenopausal women with osteoporosis.

Cummings SR, Ensrud K, Delmas PD, LaCroix AZ, Vukicevic S, Reid DM, Goldstein S, Sriram U, Lee A, Thompson J, Armstrong RA, Thompson DD, Powles T, Zanchetta J, Kendler D, Neven P, Eastell R; PEARL Study Investigators.

N Engl J Med. 2010 Feb 25;362(8):686-96. doi: 10.1056/NEJMoa0808692. Erratum in: N Engl J Med. 2011 Jan 20;364(3):290. Kucu kdeveci A [corrected to Kucukdeveci, A].

PMID:
20181970
[PubMed - indexed for MEDLINE]
Free Article
2.

Denosumab in postmenopausal women with low bone mineral density.

McClung MR, Lewiecki EM, Cohen SB, Bolognese MA, Woodson GC, Moffett AH, Peacock M, Miller PD, Lederman SN, Chesnut CH, Lain D, Kivitz AJ, Holloway DL, Zhang C, Peterson MC, Bekker PJ; AMG 162 Bone Loss Study Group.

N Engl J Med. 2006 Feb 23;354(8):821-31.

PMID:
16495394
[PubMed - indexed for MEDLINE]
Free Article
3.

Effects of flecainide on occlusion and reperfusion arrhythmias in dogs.

Lederman SN, Wenger TL, Bolster DE, Strauss HC.

J Cardiovasc Pharmacol. 1989 Apr;13(4):541-6.

PMID:
2470990
[PubMed - indexed for MEDLINE]
4.

Effects of different paced heart rates on canine coronary occlusion and reperfusion arrhythmias.

Lederman SN, Wenger TL, Harrell FE Jr, Strauss HC.

Am Heart J. 1987 Jun;113(6):1365-9.

PMID:
3591605
[PubMed - indexed for MEDLINE]
Format
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk